莱卡单抗欧洲药品管理局维持推荐阿尔茨海默氏症药物的决定。

{"title":"莱卡单抗欧洲药品管理局维持推荐阿尔茨海默氏症药物的决定。","authors":"Jacqui Wise","doi":"10.1136/bmj.r439","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9201,"journal":{"name":"BMJ : British Medical Journal","volume":"388 ","pages":"r439"},"PeriodicalIF":105.7000,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lecanemab: European drug agency upholds decision to recommend Alzheimer's drug.\",\"authors\":\"Jacqui Wise\",\"doi\":\"10.1136/bmj.r439\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9201,\"journal\":{\"name\":\"BMJ : British Medical Journal\",\"volume\":\"388 \",\"pages\":\"r439\"},\"PeriodicalIF\":105.7000,\"publicationDate\":\"2025-03-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ : British Medical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/bmj.r439\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ : British Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmj.r439","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}